JANET TAYLOR: Open Payments
NPI 1154418994 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,448 in 19 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $5,448
Speaker / faculty: $5,000Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $5,000 |
| E.R. Squibb & Sons, L.L.C. | 5 | $165 |
| Braeburn Inc. | 2 | $60 |
| Indivior Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $16 |
Products named: COBENFY, BRIXADI, SUBLOCADE, VRAYLAR, INGREZZA, ERZOFRI EXTENDED-RELEASE, REXULTI, HETLIOZ.
Industry payments across FL — which companies pay providers there.
